Insider Buying: Diploma PLC (LON:DPLM) Insider Buys 500 Shares of Stock

Diploma PLC (LON:DPLM) insider Ian El-Mokadem purchased 500 shares of the company’s stock in a transaction dated Monday, March 24th. The shares were purchased at an average cost of GBX 3,948 ($50.83) per share, for a total transaction of £19,740 ($25,415.22).

Diploma Price Performance

Shares of LON DPLM opened at GBX 3,960 ($50.98) on Thursday. The company has a quick ratio of 0.80, a current ratio of 2.17 and a debt-to-equity ratio of 62.17. The company has a market cap of £5.28 billion, a P/E ratio of 45.52, a P/E/G ratio of 2.82 and a beta of 0.75. Diploma PLC has a 52 week low of GBX 3,468 ($44.65) and a 52 week high of GBX 4,808 ($61.90). The business has a 50-day simple moving average of GBX 4,379.20 and a two-hundred day simple moving average of GBX 4,376.57.

Diploma Increases Dividend

The company also recently disclosed a dividend, which was paid on Friday, January 31st. Investors of record on Thursday, January 16th were paid a dividend of GBX 42 ($0.54) per share. The ex-dividend date of this dividend was Thursday, January 16th. This represents a yield of 0.93%. This is a boost from Diploma’s previous dividend of $17.30. Diploma’s payout ratio is currently 65.52%.

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. boosted their price objective on Diploma from GBX 4,370 ($56.26) to GBX 4,420 ($56.91) and gave the company a “neutral” rating in a research note on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, Diploma currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 4,567.50 ($58.81).

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.